Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Johannes Schetelig, Helmuth Schmidt et al.|Bone Marrow Transplantation|2020Cited by 23
Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)Aleksandra Butrym, Grzegorz Mazur, Krzysztof Mądry et al.|BMC Cancer|2015Cited by 7
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Johannes Schetelig, Helmuth Schmidt et al.|Bone Marrow Transplantation|2021Cited by 0